Person Dr Jurgen Bulitta National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE) (funded by National Health and Medical Research Council) Principal investigator of, Participant in Combating bacterial ‘superbugs‘ by innovative dosing strategies that combine available antibiotics to prevent resistance (funded by National Health and Medical Research Council) Participant in Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients. (funded by National Health and Medical Research Council) Participant in Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases (funded by National Health and Medical Research Council) Principal investigator of Targeting bacterial ïsuperbugsÍ by innovative combination dosing strategies and new antibiotics (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in Centre for REdefining antibiotic use to reDUce resistanCE and prolong the lives of antibiotics (REDUCE) (funded by National Health and Medical Research Council) Principal investigator of, Participant in Combating bacterial ‘superbugs‘ by innovative dosing strategies that combine available antibiotics to prevent resistance (funded by National Health and Medical Research Council) Participant in Innovative dosing approaches to maximise bacterial killing and prevent resistance in septic critically ill patients. (funded by National Health and Medical Research Council) Participant in Optimising the therapeutic efficacy of protein-based drugs against lymph-resident diseases (funded by National Health and Medical Research Council) Principal investigator of Targeting bacterial ïsuperbugsÍ by innovative combination dosing strategies and new antibiotics (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover